Juan Camilo Sarmiento (Juan C Sarmiento-Monroy)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Rheumatoid Arthritis

Disease Activity

Magnetic Resonance

Top Venues

Rheumatology and therapy

Diagnostics (Basel, Switzerland)

Arthritis research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy 11 (3) (2024)
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy 11 (3) (2024)
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy 11 (3) (2024)
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy 11 (3) (2024)
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy (2024)
Lorena Rodríguez-Martínez, Cristina García-Moreno, Eva Perez-Pampin, María José Gómara, Juan Camilo Sarmiento, Yolanda Lopez-Golán, José A Gómez-Puerta, Antonio Mera-Varela, Carmen Conde, Raimon Sanmartí, Isabel Haro, Antonio González
Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression. Arthritis research & therapy 25 (1) (2023)
Beatriz Frade-Sosa, Andrés Ponce, Virginia Ruiz-Esquide, Maria Jesús García-Yébenes, Rosa Morlá, Nuria Sapena, Julio Ramirez, Ana Belen Azuaga, Juan Camilo Sarmiento, Juan D Cañete, Jose A Gomez-Puerta, Raimon Sanmarti
High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study. Diagnostics (Basel, Switzerland) 12 (1) (2022)